RENAISSANCE - A multi-centre, non-interventional study of RElugolix as aNdrogen-deprivAtion therapy In patientS with advanced hormone-Sensitive prostate cANCEr

22/03/2024
22/03/2024
EU PAS number:
EUPAS1000000077
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Relugolix NIS protocol 19022024 VF.pdf

English (481.84 KB - PDF) View document
Study results
Study report
Other information